ESMO Expert Report on combination therapy in advanced prostate cancer @ ASCO GU 2022

Published 2022-03-04

Download video

Download video MP4 360p

Recommendations

04:57

Precision Medicine in Carcinoma of Unknown Primary with Alwin Krämer
57:38

ESMO Patient Guides: Let's talk about oesophageal and stomach cancers
01:35

ESMO Gastrointestinal Cancers Congress 2024: Why You Should Attend
22:49

Highlights of the 2023 San Antonio Breast Cancer Symposium With Jason Mouabbi, MD
01:34

ESMO Sarcoma and Rare Cancers 2024: Reasons To Attend
01:33

ESMO Sarcoma and Rare Cancers 2024: What you can expect by attending
01:46

#ESMOBreast24: Reasons to attend this top, international Congress for the breast cancer community
06:28

ESMO Expert Report on antibody drug conjugates in the management of urothelial cancer @ASCO GU 2022
01:48

#ELCC24: Reasons Why You Should Attend
01:08

ESMO Sarcoma and Rare Cancers 2024: Why young oncologists should attend
01:52

ESMO Targeted Anticancer Therapies Congress 2024: Global Experts On Why You Should Secure Your Seat
01:19

ESMO Gastrointestinal Cancers Congress 2024: What To Expect
03:39

Highlights from the ESMO Patient Guides event ‘Let's talk about oesophageal and stomach cancers’
01:51

#ESMOBreast24: International breast cancer experts invite you to attend
01:58

ESMO Sarcoma and Rare Cancers 2024: The Scientific Committee on why you should attend
27:44

Science of Sick Building Syndrome & Environmental Sensitivity- Ep 307 of HOME DIAGNOSIS TV Series
01:42

ESMO Congress 2023 Patient Advocacy Track Testimonial with Jana Pelouchova
01:40

#ELCC24: Co-chairs Paul Baas & Natasha Leighl on why you should attend
02:15

ESMO Congress 2023 Patient Advocacy Track Testimonial with Barbara Moss
01:57

ESMO Congress 2023 Patient Advocacy Track Testimonial with Anne Marie Baird

ESMO Expert Report on combination therapy in advanced prostate cancer @ ASCO GU 2022

Download video

Download video MP4 360p

Precision Medicine in Carcinoma of Unknown Primary with Alwin Krämer

ESMO Patient Guides: Let's talk about oesophageal and stomach cancers

ESMO Gastrointestinal Cancers Congress 2024: Why You Should Attend

Highlights of the 2023 San Antonio Breast Cancer Symposium With Jason Mouabbi, MD

ESMO Sarcoma and Rare Cancers 2024: Reasons To Attend

ESMO Sarcoma and Rare Cancers 2024: What you can expect by attending

#ESMOBreast24: Reasons to attend this top, international Congress for the breast cancer community

ESMO Expert Report on antibody drug conjugates in the management of urothelial cancer @ASCO GU 2022

#ELCC24: Reasons Why You Should Attend

ESMO Sarcoma and Rare Cancers 2024: Why young oncologists should attend

ESMO Targeted Anticancer Therapies Congress 2024: Global Experts On Why You Should Secure Your Seat

ESMO Gastrointestinal Cancers Congress 2024: What To Expect

Highlights from the ESMO Patient Guides event ‘Let's talk about oesophageal and stomach cancers’

#ESMOBreast24: International breast cancer experts invite you to attend

ESMO Sarcoma and Rare Cancers 2024: The Scientific Committee on why you should attend

Science of Sick Building Syndrome & Environmental Sensitivity- Ep 307 of HOME DIAGNOSIS TV Series

ESMO Congress 2023 Patient Advocacy Track Testimonial with Jana Pelouchova

#ELCC24: Co-chairs Paul Baas & Natasha Leighl on why you should attend

ESMO Congress 2023 Patient Advocacy Track Testimonial with Barbara Moss

ESMO Congress 2023 Patient Advocacy Track Testimonial with Anne Marie Baird

Highlights in prostate cancer from ESMO

Expert Report on latest data in the management of metastatic prostate cancer from ASCO 2022

Advanced Prostate Cancer Clinical Trials Update 2022

Prostate Cancer Highlights from ESMO 2022

Combination therapies for the treatment of prostate cancer

Expert video report on Prostate Cancer from 2021 Genitourinary Cancers Symposium

Clinical trial updates in prostate cancer at ESMO 2022

ASCO 2023 Expert Report on novelties in oncogene driven NSCLC by A. Curioni-Fontecedro

Upcoming GU cancer trials to be presented at ESMO 2022

#ESMO22 Highlights on ADT duration with post-operative radiotherapy in prostate cancer: RADICALS-HD

Highlights from ASCO GU 2022

Expert Report on novelties in the management of gynaecological malignancies from ASCO 2022

2022 GU ASCO Prostate Cancer Highlights

GU ASCO Symposium 2022 Summary

#ESMO21 Highlights on MFS analysis from comb. treatments in high-risk adv. prostate cancer: STAMPEDE

2022 ASCO Genitourinary Cancers Symposium Research Updates Webinar with Dr. Alexandra Sokolova

Highlights in biliary tract and liver cancers from ESMO WCGIC 2022